Parental Concerns and Uptake of Childhood Vaccines in Rural Tanzania – A Mixed Methods Study by Vasudevan, Lavanya et al.
University of South Carolina 
Scholar Commons 
Faculty Publications Health Services Policy and Management 
10-20-2020 
Parental Concerns and Uptake of Childhood Vaccines in Rural 
Tanzania – A Mixed Methods Study 
Lavanya Vasudevan 
Joy Noel Baumgartner 
Sara Moses 
Esther Ngadaya 
Sayoki Godfrey Mfinanga 
See next page for additional authors 
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_health_services_policy_management_facpub 
 Part of the Health Services Administration Commons, and the Health Services Research Commons 
Author(s) 
Lavanya Vasudevan, Joy Noel Baumgartner, Sara Moses, Esther Ngadaya, Sayoki Godfrey Mfinanga, and 
Jan Ostermann 
RESEARCH ARTICLE Open Access
Parental concerns and uptake of childhood
vaccines in rural Tanzania – a mixed
methods study
Lavanya Vasudevan1,2,3 , Joy Noel Baumgartner3, Sara Moses4, Esther Ngadaya4, Sayoki Godfrey Mfinanga4,5,6 and
Jan Ostermann2,3,7,8*
Abstract
Background: Vaccine hesitancy has been recognized as an important barrier to timely vaccinations around the
world, including in sub-Saharan Africa. In Tanzania, 1 in 4 children is not fully vaccinated. The objective of this
mixed methods study was to describe and contextualize parental concerns towards vaccines in Tanzania.
Methods: Between 2016 and 2017, we conducted a cross-sectional survey (n = 134) and four focus group
discussions (FGDs, n = 38) with mothers of children under 2 years of age residing in Mtwara region in Southern
Tanzania. The survey and FGDs assessed vaccination knowledge and concerns and barriers to timely vaccinations.
Vaccination information was obtained from government-issued vaccination cards.
Results: In the cross-sectional survey, 72% of mothers reported missed or delayed receipt of vaccines for their child.
Although vaccine coverage was high, timeliness of vaccinations was lower and varied by vaccine. Rural mothers
reported more vaccine-related concerns compared to urban mothers; literacy and access to information were
identified as key drivers of the difference. Mothers participating in FGDs indicated high perceived risk of vaccine-
preventable illnesses, but expressed concerns related to poor geographic accessibility, unreliability of services, and
missed opportunities for vaccinations resulting from provider efforts to minimize vaccine wastage.
Conclusions: Findings from our cross-sectional survey indicate the presence of vaccination delays and maternal
concerns related to childhood vaccines in Tanzania. In FGDs, mothers raised issues related to convenience more
often than issues related to vaccine confidence or complacency. Further research is necessary to understand how
these issues may contribute to the emergence and persistence of vaccine hesitancy and to identify effective
mitigation strategies.
Keywords: Childhood vaccinations, Parental concerns, Vaccine hesitancy, Vaccination timeliness, Tanzania, Sub-
Saharan Africa
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Background
In recent years, the coverage of routine childhood im-
munizations in sub-Saharan Africa (SSA) has stalled at
72% [1, 2]. Recurring vaccine-preventable outbreaks in
various regions of SSA and persistent vaccine-related
concerns among parents have raised worries that gains
made by immunization programs in the coverage of
childhood vaccines may be reversed [3–7]. In light of
these concerns, there is a growing emphasis on identify-
ing and mitigating vaccine hesitancy - the decision of
parents to decline or delay vaccinations for their chil-
dren [8, 9]. In the multifaceted strategy to stem vaccine-
preventable outbreaks in under-immunized children, the
WHO recognizes reduction of vaccine hesitancy as a key
global priority [8–12].
Several drivers of vaccine hesitancy have been identi-
fied in the literature, including factors related to parental
confidence in vaccines, complacency towards vaccines
and vaccination programs, and the convenience of acces-
sing vaccines [13]. These drivers may influence parental
knowledge about vaccines, experiences with vaccination
programs, and intention to vaccinate. Without effective
interventions to mitigate these drivers of parental vaccine
hesitancy, children from hesitant families will remain sus-
ceptible to vaccine-preventable diseases. However, address-
ing vaccine hesitancy is challenging. Parental concerns vary
widely based on factors such as religious, cultural, political,
geographic, or socio-economic context, vaccine type, and
mode of delivery [11, 14]. Hence, the WHO suggests that,
to be effective, interventions to address vaccine hesitancy
be tailored to, and informed by, concerns specific to the re-
spective target population [14, 15].
Of the countries in SSA, Tanzania, under the leader-
ship of the National Immunization and Vaccine Devel-
opment (IVD) programme, has one of the highest rates
of coverage of routine childhood vaccines. Over the past
several decades, the routine immunization program in
Tanzania has expanded significantly to cover eleven
vaccine-preventable diseases. In addition, the IVD has
made substantial efforts to reduce stock outs and estab-
lish a reliable supply chain to improve vaccine availabil-
ity in alignment with the Global Vaccine Action Plan’s
Reach Every District (RED) goal. Despite these efforts,
challenges to universal immunization remain, especially
in rural areas of the country. According to the 2015–16
Demographic and Health Survey (DHS), 1 in 4 children
nationally is not fully vaccinated, and many regions fall
short of the 90% coverage target set by RED [16, 17]. In
addition, there is significant variation in childhood vac-
cine coverage by region, socio-economic status, parental
education, and rurality [16, 18]. To our knowledge, while
many studies have examined broad barriers to vaccine
uptake in Tanzania, no studies have specifically looked
at parental concerns and their impact on vaccine uptake.
To bridge this knowledge gap and inform the develop-
ment of interventions to reduce vaccine hesitancy and
improve uptake of basic childhood vaccinations, we used
a mixed methods approach to describe and contextualize




The methods described in this study were part of a lar-
ger study that aimed to understand barriers to timely
vaccine uptake in southern Tanzania and develop a
digital health intervention to promote timely vaccine up-
take. The study was conducted in one urban district
(Mtwara Municipality) and one rural district (Mtwara
District Council) in Mtwara Region in Southeastern
Tanzania. Mtwara Region has an estimated population
of 1.3 million people; the two districts included in this
study have an estimated population of 336,000 [19, 20].
The Tanzania Ministry of Health, Community Develop-
ment, Gender, Elderly and Children and the national
Immunization and Vaccine Development (IVD) program
oversee the provision of routine childhood vaccinations
in Mtwara Region. This study was limited to government
health facilities which provide the vast majority of child-
hood vaccinations. In 2015–16, coverage of all basic
childhood vaccines as per national guidelines (Supple-
mentary Table 1) in Mtwara Region was estimated to be
79%, mirroring the national coverage rate of 75% [16].
Cross-sectional survey
The methods of the cross-sectional survey are reported
below in accordance with the STROBE checklist for
cross-sectional studies (Supplementary Table 2).
Study participants
Women ages 16 years or older, with children ages 12–
23months, were eligible to participate in the cross-
sectional survey on vaccination knowledge, concerns,
and practices. The minimum child age for the survey
was set to 12months to allow for the assessment of vac-
cine uptake in their first year of life.
Sample size
A priori power calculations suggested that a stratified
sample of 10–12 women per facility from 12 health facil-
ities would yield adequate statistical power (> 0.8) to
characterize differences in sociodemographic character-
istics between rural and urban mothers and to identify
medium to strong correlates of vaccine hesitancy.
Recruitment
Between May and June 2017, we used a combination of
purposive and snowball sampling strategies to recruit
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mothers from 4 urban and 8 rural government health fa-
cilities and the surrounding communities for participation
in the cross-sectional survey. Trained research assistants
approached eligible women presenting with children to
the well child clinic at participating facilities for consent
and enrollment. To reduce biases from facility-based en-
rollment, participating women were asked to identify
other potentially eligible women in their communities.
Trained research assistants approached referred women in
their homes for eligibility determination, consent, and
enrollment.
Data collection
Trained research assistants conducted cross-sectional
surveys with mothers at health facilities, homes, or other
mutually agreed-upon locations. The survey was inter-
viewer administered, and data were collected on a tablet
device using the QualtricsXM survey platform. Vaccin-
ation knowledge and concerns were assessed using
questions adapted from a WHO survey on vaccine
hesitancy [21], and a prior study (see Acknowledge-
ments). Other survey questions assessed women’s
sociodemographic characteristics, reproductive history,
and barriers to vaccinations. Children’s vaccination
histories in their first year of life, including dates of
vaccinations, were obtained from government-issued
vaccination cards.
Key outcomes
The key outcomes of interest, mothers’ vaccine hesitancy
and the timeliness of children’s vaccinations, were mea-
sured as follows:
Vaccine hesitancy: For each of 15 survey questions used
to assess vaccine hesitancy, the mother’s response was
scored as 0 if not hesitant, 1 if not sure, or 2 if hesitant
(survey items were reverse coded as needed). A vaccine
hesitancy index score was generated for each mother as
the sum of the individual item scores. The index
ranged from 0, if the mother scored not hesitant for all
items, to 30, if the mother scored hesitant on all items.
Timeliness of vaccinations: For each vaccine received by
the child, the date of vaccination was coded with a
score of 1 if timely or 0 if early, late, or missed.
Vaccinations received prior to the due date were
considered early; those received ≥28 days beyond the
due date were considered late (see Supplementary
Table 3). Timeliness of individual doses in a vaccine
series was calculated contingent on the date of receipt
of the previous dose. Thus, a child could be timely for
the receipt of the second or third dose of a vaccine
even if the previous dose was delayed.
Data analysis
Survey data were analyzed using Stata v.15 (StataCorp
LLC). Distributions of the key outcomes of interest,
sociodemographic characteristics of mothers, and other
correlates of vaccine hesitancy and vaccination decisions,
were described using means and ranges for continuous
variables and proportions for categorical variables. Vari-
ation in these characteristics between rural and urban
mothers were analyzed using Student’s t-tests and chi-
squared tests for continuous and categorical variables,
respectively. Associations between sociodemographic
characteristics, vaccine hesitancy, and vaccine coverage
and timeliness were assessed using linear least squares
regression models that accounted for clustering at the
level of the referral, i.e., each index woman enrolled
from a health facility and her community-based referrals
formed a cluster. Observations with missing data were
excluded from the respective analyses.
Focus group discussions
Study participants
Women ages 16 years or older, with children ages 0–23
months, were eligible to participate in focus group dis-
cussions (FGDs) on barriers to childhood vaccination.
Sample size
As is typical of qualitative analyses, the goal was to identify
community norms and common themes across groups.
Given broad eligibility criteria we did not anticipate signifi-
cant differences between participants across groups; groups
were expected to be similar except for their geographic lo-
cation. Due to these considerations and published reports
on qualitative sample size considerations [22–24], we deter-
mined a priori that four FGDs with 10 women per FGD
would likely be sufficient to reach saturation.
Recruitment
Between December 2016 and February 2017, a purposive
sampling approach was used to recruit mothers from
two urban and two rural government health facilities for
participation in FGDs. Trained research assistants
approached eligible women for consent and enrollment.
Data collection
Two female Tanzanian research assistants (RAs) trained
in qualitative data collection conducted four FGDs with
mothers using a semi-structured guide aimed at under-
standing locally and socio-culturally relevant barriers to
timely vaccinations. FGD domains consisted of open-
ended questions with probes on the role of women in
vaccination decision-making, and barriers to vaccine up-
take. Each FGD included approximately 10 participants
and lasted between 40 and 60 min. FGDs were audio-
recorded, transcribed in Swahili, and translated into
Vasudevan et al. BMC Public Health         (2020) 20:1573 Page 3 of 11
English for analysis. A short survey captured basic
demographic information of FGD participants; field
notes were written after the FGDs by the RAs. Owing to
logistical considerations and variations in English liter-
acy, transcripts were not returned to participants for
comments.
Data analysis
Translated FGD transcripts were uploaded into QSR
NVivo v.11, and thematic analyses were conducted utiliz-
ing four interrelated steps: reading, coding, data display,
and data reduction. Within FGDs, participants organically
discussed issues related to vaccine hesitancy. To
summarize and synthesize those discussions, transcripts
were coded by the first author using a codebook made of
a priori, structural codes based on the “3 Cs” model of
vaccine hesitancy, comprising convenience, complacency,
and confidence, with an eye towards identifying commu-
nity norms on these issues (see Supplementary Table 4)
[25]. Narrative summaries were created for each of the “3
Cs” domains and are presented below with accompanying
quotes from the mothers for illustration. The narrative




Table 1 shows the socio-demographic characteristics of the
women participating in the cross-sectional survey (n = 134).
The sample included 45 index clients enrolled from health
facilities, and 89 referrals enrolled from the surrounding
communities. There were no statistically significant differ-
ences between rural vs. urban women in the study with re-
spect to the distributions of their ages, marital status, or
employment status. However, more rural women than urban
women reported a lack of formal education (34.8% vs.
11.9%) and were unable to read and write a whole sentence
(50% vs. 14.3%). While urban women reported more house-
hold assets, rural women reported greater media exposure
(defined as watching television almost every day). Compared
to urban women, rural women also reported traveling
greater distances (walking time) to the vaccination clinic.
Figure 1 and Supplementary Figure 1 show the distribu-
tion of children’s vaccination coverage and timeliness by
12months of age. Although vaccine coverage and timeli-
ness were similar between rural and urban settings, rates
varied widely by vaccine. Vaccination coverage was lowest
for the oral polio vaccine (OPV1 and OPV3, 65.6%; OPV2,
68%; numbers not shown), and highest for the birth dose of
the Bacillus Calmette Guerin vaccine (BCG0, 92.8%)
Table 1 Sociodemographic characteristics of women participating in the cross-sectional survey (N = 134)
Characteristic Response categories All participants
N or mean % or
(sd)
Urban participants
N or mean %
or (sd)
Rural participants
N or mean %
or (sd)
Significance
N = 134 N = 42 N = 92
Age (in years) 26.5 (6.9) 25.0 (5.0) 27.2 (7.6)
Education None 37 27.6 5 11.9 32 34.8 ***
Some primary school 12 9.0 1 2.4 11 12.0
Primary school completed 58 43.3 19 45.2 39 42.4
Secondary school 27 20.1 17 40.5 10 10.9
Marital status Married 84 62.7 29 69.0 55 59.8 ns
Divorced / separated / widowed 30 22.4 6 14.3 24 26.1
Never married 20 14.9 7 16.7 13 14.1
Parity Any prior children 77 57.5 19 45.2 58 63.0 ns
No prior children 57 42.5 23 54.8 34 37.0
Literacy Unable to read and write whole sentence 52 38.8 6 14.3 46 50.0 ***
Able to read and write whole sentence 82 61.2 36 85.7 46 50.0
Media exposure Watches television almost every day 103 76.9 19 45.2 84 91.3 ***
Watches television weekly or less 31 23.1 23 54.8 8 8.7
Household assets Number of assets (0-10) 2.7 (2.5) 4.7 (2.7) 1.8 (1.8) ***
Walking time to dispensary <15 minutes 81 60.4 32 76.2 49 53.3 **
15-29 minutes 27 20.1 8 19.0 19 20.7
30+ minutes 26 19.4 2 4.8 24 26.1
Notes: ***p < 0.001, **p < 0.01. *p < 0.05, ns not significant
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and the second dose of the pentavalent vaccine
(Penta2, 92.8%). With the exception of BCG0, timeli-
ness of vaccinations was low for all vaccines, with the
largest delays reported in the first dose of the
Measles-Rubella vaccine (MR1, 43.2% timely).
A majority of the mothers (72%, n = 96) participating
in the survey self-reported that their child did not re-
ceive vaccine(s) they were supposed to get (results not
shown). Primary reasons reported by mothers for
missed vaccinations were the unavailability of vaccines
(n = 42, 44%) and being asked to return at another time
by clinic staff (n = 35, 36%). Other reasons included
maternal or child sickness, travel, and forgetfulness.
Reasons related to complacency or vaccine confidence
were mentioned, but with very low frequencies. A few
women thought vaccines were not needed (n = 4), not
effective (n = 1), had a bad experience with previous
vaccination (n = 1), or had a family member or friend
who advised against it (n = 1).
Figure 2 shows the distribution of mothers’ concerns
and knowledge related to vaccines. While most women
(93%, n = 125) correctly reported knowing that vaccines
can prevent deadly diseases, more than a quarter (28.4%,
n = 38) did not know that vaccines were only effective
when given before a child is ill. Nearly as many mothers
(23.9%, n = 32) did not know that multiple doses of a
vaccine may be required before full immunization is
achieved. The top concern (48.5%, n = 65) was related to
the receipt of multiple vaccines in a single appointment.
Overall, 79% of mothers (n = 99) reported at least one
vaccine-related concern, and 32% of mothers (n = 43)
reported three or more vaccine-related concerns. On
average, urban women had a lower vaccine hesitancy
score compared to rural women (Fig. 3).
Table 2 shows the results of four models of vaccine
hesitancy. Model 1 describes the mean difference in
hesitancy between rural and urban mothers: rural resi-
dence was associated with significantly higher vaccine
hesitancy (p < 0.001). Model 2 (“Information model”)
adds variables indicative of access to information (which
is conceptually related to the confidence and compla-
cency domains of the 3 C’s model): literacy (p = 0.033)
and media exposure (p = 0.024), but not formal educa-
tion, were negatively associated with vaccine hesitancy.
In Model 3 (“Access model”), variables related to phys-
ical access and household economic wellbeing (which
are related to the convenience domain of the 3 C’s
model) were not associated with vaccine hesitancy.
Model 4 includes the full set of covariates; only literacy
(p = 0.041) and media exposure (p = 0.037) were signifi-
cantly associated with vaccine hesitancy. In Models 2–4,
after controlling for demographic, information, access,
and/or other characteristics, the difference in vaccine
hesitancy between rural and urban mothers was no lon-
ger statistically significant at conventional levels (range
p = 0.057 to p = 0.109).
Focus group discussions
In total, 38 mothers participated in the FGDs. Mothers
in the FGDs were between 17 and 37 years of age. While
all women reported that their youngest child received
vaccines, eight women (21%) women reported
Fig. 1 Childhood vaccination coverage and timeliness for urban and rural children for vaccinations due before 12months of age (n = 125). Notes:
Percentages are based on vaccination dates reported on government-issued vaccination cards for 37 urban and 88 rural children 12–23months
of age. See Supplemental Table 1 for abbreviations of vaccinations. PCV* and Rota* percentages are based on data for 34 urban and 85 rural
children. Nine children were excluded due to missing vaccination cards
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vaccination delays and 2 women (5%) reported missed
vaccinations.
All “3 C’s” (convenience, confidence and complacency)
were discussed by the women in the FGDs. Concerns
predominantly centered on the convenience of accessing
vaccines, followed by issues related to vaccine con-
fidence. Only a few comments pertained to compla-
cency, and were usually based on experiences of
FGD participants in community settings and di-
rected at “other” women. Comments related to sat-
isfaction with the vaccination experience and trust
in provider recommendations and actions were
mentioned in the context of convenience, confi-
dence, and complacency.
“3 Cs” of vaccine hesitancy: Convenience
Women in the FGDs highlighted a number of chal-
lenges related to the convenience of getting a child
vaccinated. These included poor geographic accessi-
bility of facilities and lack of affordable transporta-
tion options, especially for women residing in rural
areas.
“Some of us come very far from here, so we have a
problem of transport. Sometimes the date for vaccin-
ation may reach but I miss transport to go to the
hospital.”
Rural Mother
In general, women expressed frustration when ex-
periencing delays beyond their control, primarily
due to unreliability of supplies needed for vaccin-
ation at the health facilities to keep refrigerators
functioning.
“We do not miss completely but vaccinations are
sometimes delayed because of shortage of supplies.”
Rural Mother
Women also expressed displeasure at being turned
away when, in an effort to minimize vaccine wastage,
providers were reluctant to open multidose vials for the
small number of children present to be vaccinated.
“I think the idea of telling us to come back another
day because we are only two or three should end
Fig. 2 Distribution of maternal knowledge, attitudes, and concerns about childhood vaccines (N = 134). Notes: Numbers indicate counts of
women with negative (red) or ambivalent (grey) responses to vaccination-related knowledge and attitude questions. Confidence and importance
items were assessed on a 3-point scale including ‘very much’, ‘somewhat’, and ‘not at all’. Knowledge and attitude items were assessed on a 3-
point scale including ‘agree’, ‘not sure’, and ‘disagree’. # indicates positively-framed items; all other items were reverse-coded
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because we have left our activities to come on that
day and others who didn’t come maybe they are sick
at home so how long should we wait for them, I
think that habit should stop and we should get the
vaccine no matter how many we are.”
Urban Mother
“3 Cs” of vaccine hesitancy: Complacency
Comments relating to complacency described varying
knowledge about vaccines, motivation to vaccinate, and
household decision-making and support for vaccinations.
Similar to the study’s quantitative findings, women in the
FGDs demonstrated high perceived risk of vaccine-
Table 2 Correlates of vaccine hesitancy among women participating in the cross-sectional survey (N = 134)
Characteristic Response category Rural vs. urban Information model Access model Full model
Place of residence Rural (vs. urban) 2.44*** (0.54) 1.16 (0.71) 1.79 (0.85) 1.45 (0.74)
Mother's age (in years) -0.07 (0.07)
Education Some primary school (vs. no schooling) -0.47 (1.04) -1.10 (1.37)
Primary school completed 1.35 (1.39) 1.00 (1.73)
Secondary school 0.91 (1.54) 0.43 (1.87)
Marital status Divorced / separated / widowed -0.25 (0.76)
Never married -0.08 (0.88)
Parity First child (vs. prior children) -0.01 (0.84)
Literacy Able to read and write whole sentence (vs. unable) -2.61* (1.19) -2.66* (1.26)
Media exposure Watches TV almost every day (vs. weekly or less) -1.53* (0.65) -2.39* (1.12)
Household assets # of assets in household (0-10) -0.19 (0.14) 0.26 (0.26)
Distance to nearest
dispensary
15-29 minutes walking (vs. <15 min) 1.02 (0.82) 0.91 (0.79)
30+ minutes walking 0.43 (0.65) 0.52 (1.04)
Constant 2.90*** (0.36) 5.01*** (0.89) 3.57*** (0.80) 6.26** (2.27)
Number of observations 134 134 134 134
R-squared 0.10 0.18 0.13 0.21
AIC 712.9 709.7 714.8 718.9
Notes: Estimates from linear least squares regression models. Robust standard errors in parentheses
*** p < 0.001, ** p < 0.01, * p < 0.05
Abbreviations: min Minutes, AIC Akaike information criterion
Fig. 3 Distribution of vaccine hesitancy in rural vs. urban areas (N = 134). Notes: Vaccine hesitancy index defined using mothers’ responses to 15
questions assessing maternal knowledge, attitudes, and concerns about childhood vaccines; each question is scored on a scale of 0–2; see Fig. 2.
A higher index indicates greater vaccine hesitancy
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preventable illnesses, and generally agreed that vaccines
were important for their child’s health. When probed about
household decision-making related to the child’s vaccina-
tions, most women suggested either having autonomy or
being able to make shared decisions with their spouses.
Women reported varied roles for the father of the child in
vaccination decision-making and uptake. These roles
ranged from escorting the mother and child to the health
facility, indifference to what health services the child may
have received, to scolding mothers for the occurrence of
post-vaccination fever in children. One mother talked about
the support she received from her husband as follows:
“…I thank God because when it comes to his chil-
dren, my husband provides a lot of care and with
regards to vaccinations, when I forget he usually re-
minds me like today. He is the one who told me the
day before yesterday that today was the day for vac-
cination that I should bring the child and as we
speak I came along with him so he is just outside”
Rural Mother
Another mother articulated the household dynamics of
vaccination decision-making as follows:
“The mother is the one who makes all the decisions
concerning the child, because if you tell him the vac-
cination date, other men start quarrelling and it can
reach separation: ‘I don’t want my child to be
injected, you will give her fever, you will give me
problems and later I will take her to the hospital
again’, so you have to say ‘No’, that it protects the
child from other things, so you have to make it a pri-
ority to take a child to the clinic to get the shots”
Urban Mother
Some women in the focus groups referred to others in
the community who lacked knowledge about vaccines or
knowledge of its importance, and suggested a role for
health providers in educating them.
“In short they think that after getting pregnant and giv-
ing birth safely, they just leave without caring, they
don’t care whether the children are vaccinated or not,
so long as they have given birth then they think that the
child will just grow so they don’t care about vaccinating
the child.”
Rural Mother
“3 Cs” of vaccine hesitancy: Confidence
Many women in the FGDs expressed concerns related to
the discomfort and minor side effects of vaccinations in
children (e.g., crying, and formation of abscesses). In re-
sponse to a question on multiple vaccinations
administered during one visit, one woman said her deci-
sion to vaccinate her child had changed because of mul-
tiple injections, while others said their decision remained
the same. In general, women reported that they relied
on the doctor or nurse to tell them about which vaccines
are due and when they are scheduled.
“We don’t make choices, it is the nurse who tells us
the date and place to take our babies for vaccin-
ation. We are always told that when we go for clinic,
the nurse looks at the card and tells me a date I am
supposed to bring my baby for vaccination. That day
I keep in mind”
Rural Mother
Discussion
To our knowledge, this study is the first to assess vac-
cine hesitancy and parental concerns and their associ-
ation with vaccine uptake in Tanzania. Among 134 rural
and urban children in Southern Tanzania, vaccination
coverage was high, but vaccination timeliness was low.
Both quantitative survey data from the mothers of these
children, and qualitative data from FGDs suggest delays
in vaccinations, and that convenience, confidence, and
to a lesser degree, complacency, may contribute to these
delays. Two previous studies in the same area described
low timeliness of vaccine uptake in the region but did
not examine parental concerns [26, 27].
According to the 2015–16 Tanzania DHS, there are
stark differences in the uptake of childhood vaccines in
urban and rural settings [16]. These disparities are
highlighted in our study in the varying number and na-
ture of concerns among urban and rural women. Results
from our cross-sectional survey suggest that access to in-
formation may be a key driver of differences between
rural and urban areas. Based on a study of community
vaccine perceptions, Chambongo et al. suggested health
promotion, community sensitization, and improving
provider-patient relationships, as strategies for increasing
vaccination coverage among rural Tanzanian children
[28]. Similar recommendations on the need to improve
caregiver knowledge about vaccines were published by
Magodi et al. [27].
Much of the literature on vaccine hesitancy focuses on
high-income countries (HICs), where the prevalence of
parental concerns towards vaccines and the link between
parental concerns and sub-optimal vaccine uptake are
well established [10, 29]. In contrast to HICs, data from
low- and middle-income countries (LMICs) on parental
concerns and their impact on vaccine uptake are lagging
[30]. While parental concerns towards vaccines in HICs
focus on risk-benefit tradeoffs of vaccines and issues like
autism [31], concerns in LMICs tend to focus on a lack
of information about vaccines and the benefits of
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vaccinations, and a lack of access to vaccines [13]. Much
of the focus in Tanzania and other LMICs remains on
improving the geographic coverage of vaccination pro-
grams. While increasing exposure to vaccines has re-
sulted in greater awareness and dialog around vaccines
in Tanzania, there may be insufficient emphasis on
studying and mitigating the emergence or persistence of
parental concerns.
An important finding of our study is that higher literacy
and media exposure are associated with lower vaccine hesi-
tancy among study participants. The impact of literacy is
consistent with other published reports [32, 33]. Exposure
to negative media content, however, has been associated
with higher vaccine hesitancy in other HICs and LMICs
[34–36]. In our study, we did not assess sentiments associ-
ated with specific media content related to vaccines. Fur-
ther research is needed to explain the detailed relationships
between media exposure relevant to vaccinations, senti-
ments, and vaccine hesitancy in Tanzania.
In sub-Saharan Africa, additional challenges have been
noted in the form of infrequent health system contacts
and missed opportunities for vaccination [4, 6, 27, 37–
39]. The WHO definition of vaccine hesitancy focuses
on the choice of parents to delay or refuse vaccines
when vaccines are available as opposed to non-
vaccination due to lack of services or interruptions to
the vaccine supply or cold-chain. In our focus groups,
mothers expressed frustration when turned away from
health facilities despite their interest in vaccinations, ei-
ther because there were insufficient numbers of children
for vaccination that day, or due to lack of electricity
impacting operation of the vaccine refrigerators. Policies
for minimizing vaccine wastage may contribute to
missed opportunities for vaccinations in these settings,
particularly in rural areas with lower-volume health fa-
cilities and greater geographic access barriers for
mothers. We posit that service unavailability or refusal
could contribute to reduced trust, perceived unreliability
of the health system, and decreased convenience of
accessing vaccines. Further research is necessary to
understand how lack of service availability, low reliabil-
ity, and inconvenience may contribute to the emergence
of vaccine hesitancy in otherwise non-hesitant families.
The focus group participants in this study agreed on
the key role of mothers in healthcare decisions related to
their child, while also describing various degrees of in-
volvement by fathers. Male involvement in maternal and
child health services has been shown to improve uptake
of preventive health behaviors [40]. In the context of
vaccinations, male involvement may help reduce delays
in instances where the mother is sick, traveling, or
otherwise unable to bring the child to the health facility.
Further investigations of paternal perceptions towards
vaccines and factors influencing their participation in
child health services are important to understand the
household dynamics surrounding vaccination decision-
making and access of vaccination services.
Study limitations include the small sample size and the
reliance on facility-based recruitment (sampling bias); in
addition, the validity of the vaccine hesitancy measure in
this context is unknown. There are currently few validated
surveys to measure vaccine hesitancy in LMICs [41, 42].
Currently available scales for measuring vaccine hesitancy
such as the Vaccine Hesitancy Scale [31] and the Parent At-
titude about Childhood Vaccines (PACV) [21, 43, 44] are
validated among parents from HICs. Recently, Wallace
et al. presented findings from the development of a scale to
measure parental vaccine acceptance in Ghana, but this
scale is yet to be tested in other sub-Saharan Africa settings
for its reliability and validity in measuring vaccine hesitancy
[45]. Within these limitations, our study did not identify a
statistically significant link between parental concerns and
vaccine uptake or timeliness in Southern Tanzania; a larger
sample size, a representative community-based sample, and
locally validated measures of hesitancy may be needed to
derive conclusive evidence about the link between parental
concerns and vaccine uptake and timeliness. Finally, FGDs
were designed to capture barriers to timely vaccine uptake
broadly, and discussions were not tailored specifically to
capture vaccine hesitancy.
Conclusion
The findings of this study support existing literature on
low timely vaccine coverage in children from Southeastern
Tanzania [26, 27] and describe an underlying, unad-
dressed, current of vaccine hesitancy. The study highlights
missed opportunities for routine immunization, common
parental concerns, and the potential role of information
access, which, if addressed, may improve childhood vac-
cination rates, especially in rural areas. Further studies are
needed to examine reasons for higher vaccine hesitancy
among rural mothers and develop interventions to reduce
these concerns. Tailored behavior change strategies for
implementation within routine immunization services
may hold potential to improve the timeliness of childhood
vaccinations in Tanzania. The study findings were shared
with representatives of the national Immunization and
Vaccine Development program and were well received. A
community health worker-delivered intervention for im-
proving vaccination knowledge and beliefs is currently be-
ing piloted in Mtwara Region [46].
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